Price
Target price
€20.72
€20.72
-1.380%
-0.29
-1.380%
€33.55
09:31 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
We can see a decrease in the price for Corcept Therapeutics Inc.. Compared to yesterday it has lost -€0.290 (-1.380%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Corcept Therapeutics Inc..
With a target price of 33 € there is a hugely positive potential of 59.27% for Corcept Therapeutics Inc. compared to the current price of 20.72 €.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Corcept Therapeutics Inc. | -1.380% | -0.186% | -5.702% | 4.369% | -28.333% | 8.040% | - |
Avid Bioservices Inc | - | -1.563% | 1.613% | -64.804% | 3.279% | -64.000% | 54.753% |
Rockwell Medical Inc. | 1.620% | -4.810% | -3.193% | -26.923% | -20.034% | -85.152% | -96.854% |
Gritstone Oncology Inc | 10.300% | 9.065% | -69.921% | -67.350% | -58.881% | -89.974% | - |
Comments
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for CORT provided by MarketBeat